Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial

BACKGROUND: An elevated level of serum uric acid (SUA) is associated with an increased risk of cardiovascular disease. Pharmacological intervention with urate-lowering agents, such as the conventional purine analogue xanthine oxidase (XO) inhibitor, allopurinol, has been used widely for a long perio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Atsushi, Taguchi, Isao, Teragawa, Hiroki, Ishizaka, Nobukazu, Kanzaki, Yumiko, Tomiyama, Hirofumi, Sata, Masataka, Sezai, Akira, Eguchi, Kazuo, Kato, Toru, Toyoda, Shigeru, Ishibashi, Ryoichi, Kario, Kazuomi, Ishizu, Tomoko, Ueda, Shinichiro, Maemura, Koji, Higashi, Yukihito, Yamada, Hirotsugu, Ohishi, Mitsuru, Yokote, Kotaro, Murohara, Toyoaki, Oyama, Jun-ichi, Node, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176100/
https://www.ncbi.nlm.nih.gov/pubmed/32320401
http://dx.doi.org/10.1371/journal.pmed.1003095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176100/
https://www.ncbi.nlm.nih.gov/pubmed/32320401
http://dx.doi.org/10.1371/journal.pmed.1003095

Ejemplares similares